eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
upgrade to premium
.
. is putting his shoulder into legislation that would help others access the same sort of care he received when he suffered a stroke midway through his playing career.
.
.